EMBRYOLY Integrates with VRepro
EMBRYOLY Integrates with Prominent Electronic Medical Record System VRepro to improve Workflow Efficiency in IVF Centers 30.09.2024 ImVitro has announced the integration of its Artificial Intelligence (AI)-powered embryo management software, EMBRYOLY, with the prominent electronic medical record (EMR) VRepro available in fertility clinics across Europe, Central and South America, and…
Read MoreImVitro’s CEO & Founder pitches at Slush
ImVitro’s CEO and Founder, Alexandra Boussommier-Calleja was invited to speak at the world’s leading startup event. Watch the video here to hear about how ImVitro is helping IVF centers be more efficient.
Read MoreLes Echos cites ImVitro
“[ImVitro] a levé 3,5 millions d’euros depuis sa création en 2019, propose un score de probabilité fondé sur un algorithme alimenté par 60.000 vidéos d’embryons associées à leur transformation en grossesse ou non.” [EN translation]: “[ImVitro] has raised 3.5 million euros since its founding in 2019, and outputs a score…
Read MoreImVitro featured in The Guardian
Pathways to Parenthood launched in The Guardian the 27th of September, aiming to spotlight the different options available to patients for starting a family as well as the technologies that help their IVF centers get there faster, such as our SaaS platform EMBRYOLY. We’re proud that Mediaplanet invited us to…
Read MoreImVitro on Business Insider
“ImVitro’s mission is to increase the number of successful IVF treatments among patients. The startup has developed an operating system that uses AI to automate the evaluation of embryos…[and] takes into account other data points, such as a patient’s BMI and uterus receptivity, to hone predictions for embryologists.” Read the…
Read MoreBiopharma Trend cites ImVitro
“With a team of AI, medtech, and regulatory experts, ImVitro is spearheaded by Dr. Alexandra Boussommier, a highly skilled biomedical engineer trained in Switzerland, the UK, and the US. The company’s flagship product, EMBRYOLY, is a B2B SaaS platform that harnesses computer vision and AI to enhance the imaging process…
Read MoreImVitro featured in French startup magazine Maddyness
“La solution d’ImVitro, baptisée EMBRYOLY, analyse les vidéos des microscopes pour faire gagner du temps aux cliniciens, apporter de la transparence aux patients, éliminer les erreurs humaines et fournir des prédictions fiables à grande échelle.” [EN translation]: “ImVitro’s product, called EMBRYOLY, analyzes microscope videos to save clinicians time, bring transparency…
Read MoreLibération talks about ImVitro
For our francophone readers, check out the article about ImVitro today published on the Dossier santé of the newspaper Libération. It is great to see our work talked on such a well known media alongside other exciting medical innovations.
Read MoreAlexandra on the podcast “Le déclic DeepTech”
Our CEO was invited to talk about her path as a researcher turned entrepreneur on the podcast “Le déclic Deeptech” (in French) targeting the community of researchers and to help understand what and who might have been the reason to leave research and start a company. Listen to the podcast…
Read MoreImVitro on Entrepreneur First’s podcast
Listen to this episode from Entrepreneur First‘s podcast hosted by Alice Bentinck, where our CEO and founder Alexandra along with Hana Janebdar, CEO and founder of Juno Bio discuss founding companies engineering the future of reproductive healthcare. Both founders explore how their companies are using cutting edge technology to close…
Read MoreImVitro on BMSMARTV
At ImVitro, we want to help IVF patients by helping their doctors make the most of their data. This is why we invited one of our partner embryologists to join us on BSMARTV to discuss their needs which are at the heart of our development. Thank you to BSMART for…
Read More